CD133+ cells isolated from glioblastoma tumors preferentially activated the DNA damage checkpoint protein, Chk1 and Chk2 kinases [76], and repaired radiation-induced DNA damage more effectively than CD133- glioblastoma cells [76]. This evidence concerns the gene CHEK2 and glioblastoma.